Rapid, -insensitive, Dual-band Quasi-adiabatic Saturation Transfer with Optimal Control for Complete Quantification of Myocardial ATP Flux
Overview
Authors
Affiliations
Purpose: Phosphorus saturation-transfer experiments can quantify metabolic fluxes noninvasively. Typically, the forward flux through the creatine kinase reaction is investigated by observing the decrease in phosphocreatine (PCr) after saturation of γ-ATP. The quantification of total ATP utilization is currently underexplored, as it requires simultaneous saturation of inorganic phosphate ( ) and PCr. This is challenging, as currently available saturation pulses reduce the already-low γ-ATP signal present.
Methods: Using a hybrid optimal-control and Shinnar-Le Roux method, a quasi-adiabatic RF pulse was designed for the dual saturation of PCr and to enable determination of total ATP utilization. The pulses were evaluated in Bloch equation simulations, compared with a conventional hard-cosine DANTE saturation sequence, before being applied to perfused rat hearts at 11.7 T.
Results: The quasi-adiabatic pulse was insensitive to a >2.5-fold variation in , producing equivalent saturation with a 53% reduction in delivered pulse power and a 33-fold reduction in spillover at the minimum effective . This enabled the complete quantification of the synthesis and degradation fluxes for ATP in 30-45 minutes in the perfused rat heart. While the net synthesis flux (4.24 ± 0.8 mM/s, SEM) was not significantly different from degradation flux (6.88 ± 2 mM/s, P = .06) and both measures are consistent with prior work, nonlinear error analysis highlights uncertainties in the P -to-ATP measurement that may explain a trend suggesting a possible imbalance.
Conclusions: This work demonstrates a novel quasi-adiabatic dual-saturation RF pulse with significantly improved performance that can be used to measure ATP turnover in the heart in vivo.
Lygate C Clin Sci (Lond). 2024; 138(8):491-514.
PMID: 38639724 PMC: 11040329. DOI: 10.1042/CS20230616.
Kerr M, Dennis K, Carr C, Fuller W, Berridge G, Rohling S FASEB J. 2021; 35(8):e21765.
PMID: 34318967 PMC: 8662312. DOI: 10.1096/fj.202100394R.
Miller J, Valkovic L, Kerr M, Timm K, Watson W, Lau J Magn Reson Med. 2021; 85(6):2978-2991.
PMID: 33538063 PMC: 7986077. DOI: 10.1002/mrm.28647.